Vitalhub Corp. (TSE:VHI – Free Report) – Analysts at Raymond James cut their Q3 2025 earnings per share (EPS) estimates for Vitalhub in a research note issued on Sunday, May 11th. Raymond James analyst M. Freeman now forecasts that the company will earn $0.05 per share for the quarter, down from their previous forecast of $0.06. Raymond James currently has a “Moderate Buy” rating on the stock. The consensus estimate for Vitalhub’s current full-year earnings is $0.23 per share. Raymond James also issued estimates for Vitalhub’s Q3 2026 earnings at $0.07 EPS and FY2027 earnings at $0.35 EPS.
Several other equities analysts also recently commented on the company. TD Securities upped their price objective on Vitalhub from C$13.00 to C$14.00 and gave the company a “buy” rating in a research note on Monday, March 31st. Canaccord Genuity Group upped their price objective on Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research note on Thursday, January 16th. Finally, Scotiabank set a C$14.00 price objective on Vitalhub and gave the company an “outperform” rating in a research note on Thursday, January 30th. Four equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of C$12.90.
Vitalhub Trading Down 1.9%
Vitalhub stock opened at C$10.48 on Tuesday. Vitalhub has a 12 month low of C$6.60 and a 12 month high of C$12.34. The business’s 50 day simple moving average is C$9.99 and its 200 day simple moving average is C$10.64. The company has a market cap of C$566.89 million, a price-to-earnings ratio of 170.45, a PEG ratio of 1.18 and a beta of 1.26.
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
- Five stocks we like better than Vitalhub
- The Significance of Brokerage Rankings in Stock Selection
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- What is a Dividend King?
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
- Profitably Trade Stocks at 52-Week Highs
- 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.